Contrast Nephropathy | Dye induced Kidney Disease
Compromise of kidney function following imaging studies or surgery is one of the most common reasons for nephrology consultation.
The treatment and prevention of contrast or dye induced nephropathy is an evolving science.
The studies listed below will discuss the management of acute and chronic kidney disease precipted by the dyes required for medical imaging.
Contrast Dye Nephropathy
Updated January 13 2013
|
Hemodialysis.com Author Interview: Michael Osthoff, MD
Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial
Michael Osthoff, Vanja Piezzi, Theresia Klima, Andreas Christ, Ivana Marana, Sabina Hartwiger, Tobias Breidthardt, Giancarlo Marenzi, Marten Trendelenburg, Christian Mueller BMC Nephrology 2012, 13:99 (3 September 2012)
|
Hung YM, Lin SL, Hung SY, Huang WC, Wang PY.
Yao-Min Hung, Division of Nephrology, Jiannren Hospital,
Kaohsiung 813, Taiwan, China.
|
Cardiac Data Solutions study warrants increased focus on contrast induced nephropathy protocols to reduce renal complications
CHICAGO, March 29, 2012 /PRNewswire via COMTEX/ -- Incidences of renal complications, specifically acute renal failure (ARF) and new hemodialysis (HD), continue to increase significantly among Medicare beneficiaries (MB) admitted for percutaneous coronary intervention (PCI). While patients admitted with impaired renal function are at increased risk, approximately 10 percent of elective patients will suffer renal complications without prior indicators. These findings warrant more focus on implementation of a contrast induced nephropathy (CIN) protocol to reduce complications, according to a study by Cardiac Data Solutions, Inc., presented at the American College of Cardiology 61st Scientific Sessions in Chicago. |
Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, Golia B, Ricciardelli B, Condorelli G; for the REMEDIAL II Investigator
Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples.
Circulation. 2011 Aug 11
|
Author Interview Dr. Hitinder S. Gurm
Renal Function-Based Contrast Dosing to Define Safe Limits of Radiographic Contrast Media in Patients Undergoing Percutaneous Coronary Interventions
Hitinder S. Gurm, MD*,*, Simon R. Dixon, MBChB , Dean E. Smith, PhD, MPH*, David Share, MD*, Thomas LaLonde, MD , Adam Greenbaum, MD , Mauro Moscucci, MD, MBA|| BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry
* Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical Center, Ann Arbor, Michigan
 Department of Cardiovascular Medicine, Beaumont Healthcare, Royal Oak, Michigan
 Department of Internal Medicine, St. John Hospital, Detroit, Michigan
 Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan
|| Department of Medicine, University of Miami Medical Center, Miami, Florida
J Am Coll Cardiol, 2011; 58:907-914, doi:10.1016/j.jacc.2011.05.023
|
|
|
|
|
|
Raingruber B, Kirkland-Walsh H, Chahon N, Kellermann M.
|
|
|
Nephrology (Carlton). 2010 Mar;15(2):165-70.
Kandula P, et al
|
|
Cystatin C and Contrast-Induced Acute Kidney Injury
Carlo Briguori, MD, PhD; Gabriella Visconti, MD; Natalia V. Rivera, PhD; Amelia Focaccio, MD; Bruno Golia, MD; Rosalia Giannone, MD; Diletta Castaldo, MD; Francesca De Micco, PhD; Bruno Ricciardelli, MD; Antonio Colombo, MD
From the Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples
|
hemodialysis Keywords | hemodialysis Tags | hemodialysis Keyword Cloud
| |
|
|
|
